Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.19 Billion CNY | 0.87% |
| 2022 | 1.18 Billion CNY | 8.49% |
| 2021 | 1.09 Billion CNY | -21.85% |
| 2020 | 1.39 Billion CNY | 69.02% |
| 2019 | 825.96 Million CNY | 1.55% |
| 2018 | 813.38 Million CNY | 14.32% |
| 2017 | 711.47 Million CNY | 19.71% |
| 2016 | 594.31 Million CNY | 56.19% |
| 2015 | 380.5 Million CNY | 31.67% |
| 2014 | 288.99 Million CNY | 23.06% |
| 2013 | 234.83 Million CNY | 28.83% |
| 2012 | 182.28 Million CNY | 15.29% |
| 2011 | 158.1 Million CNY | 10.07% |
| 2010 | 143.63 Million CNY | 38.85% |
| 2009 | 103.44 Million CNY | 19.85% |
| 2008 | 86.31 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 264.99 Million CNY | 9.37% |
| 2024 Q2 | 269.6 Million CNY | 1.74% |
| 2024 Q3 | 271.03 Million CNY | 0.53% |
| 2023 Q4 | 242.28 Million CNY | -15.43% |
| 2023 Q1 | 344.56 Million CNY | 9.18% |
| 2023 Q2 | 320.66 Million CNY | -6.94% |
| 2023 FY | 1.19 Billion CNY | 0.87% |
| 2023 Q3 | 286.49 Million CNY | -10.66% |
| 2022 FY | 1.18 Billion CNY | 8.49% |
| 2022 Q3 | 310.12 Million CNY | 16.5% |
| 2022 Q1 | 291.79 Million CNY | -5.14% |
| 2022 Q2 | 266.19 Million CNY | -8.77% |
| 2022 Q4 | 315.57 Million CNY | 1.76% |
| 2021 Q2 | 263.79 Million CNY | 8.68% |
| 2021 Q1 | 242.72 Million CNY | -17.58% |
| 2021 Q3 | 276.9 Million CNY | 4.97% |
| 2021 Q4 | 307.58 Million CNY | 11.08% |
| 2021 FY | 1.09 Billion CNY | -21.85% |
| 2020 FY | 1.39 Billion CNY | 69.02% |
| 2020 Q4 | 294.5 Million CNY | -9.29% |
| 2020 Q3 | 324.65 Million CNY | -41.45% |
| 2020 Q2 | 554.47 Million CNY | 149.34% |
| 2020 Q1 | 222.37 Million CNY | 2.54% |
| 2019 Q4 | 216.87 Million CNY | -3.61% |
| 2019 FY | 825.96 Million CNY | 1.55% |
| 2019 Q1 | 190.18 Million CNY | -12.15% |
| 2019 Q2 | 193.9 Million CNY | 1.95% |
| 2019 Q3 | 224.99 Million CNY | 16.04% |
| 2018 Q3 | 207.95 Million CNY | 2.06% |
| 2018 Q2 | 203.75 Million CNY | 10.03% |
| 2018 Q4 | 216.48 Million CNY | 4.1% |
| 2018 FY | 813.38 Million CNY | 14.32% |
| 2018 Q1 | 185.18 Million CNY | -4.5% |
| 2017 Q4 | 193.9 Million CNY | -0.77% |
| 2017 FY | 711.47 Million CNY | 19.71% |
| 2017 Q1 | 157.28 Million CNY | -12.88% |
| 2017 Q3 | 195.4 Million CNY | 18.52% |
| 2017 Q2 | 164.87 Million CNY | 4.83% |
| 2016 Q2 | 136.84 Million CNY | 4.56% |
| 2016 FY | 594.31 Million CNY | 56.19% |
| 2016 Q1 | 130.87 Million CNY | 3.14% |
| 2016 Q4 | 180.52 Million CNY | 23.59% |
| 2016 Q3 | 146.06 Million CNY | 6.74% |
| 2015 Q2 | 65.81 Million CNY | -11.71% |
| 2015 Q4 | 126.89 Million CNY | 12.04% |
| 2015 Q3 | 113.25 Million CNY | 72.1% |
| 2015 FY | 380.5 Million CNY | 31.67% |
| 2015 Q1 | 74.53 Million CNY | -20.22% |
| 2014 Q2 | 65.49 Million CNY | 5.93% |
| 2014 Q3 | 68.23 Million CNY | 4.18% |
| 2014 Q4 | 93.43 Million CNY | 36.93% |
| 2014 FY | 288.99 Million CNY | 23.06% |
| 2014 Q1 | 61.82 Million CNY | -0.71% |
| 2013 Q1 | 48.19 Million CNY | -19.29% |
| 2013 Q3 | 59.36 Million CNY | -8.69% |
| 2013 Q4 | 62.26 Million CNY | 4.9% |
| 2013 FY | 234.83 Million CNY | 28.83% |
| 2013 Q2 | 65 Million CNY | 34.89% |
| 2012 Q1 | 32.6 Million CNY | -21.71% |
| 2012 Q4 | 59.71 Million CNY | 15.73% |
| 2012 Q3 | 51.59 Million CNY | 34.48% |
| 2012 FY | 182.28 Million CNY | 15.29% |
| 2012 Q2 | 38.36 Million CNY | 17.66% |
| 2011 Q1 | 31.6 Million CNY | -29.61% |
| 2011 FY | 158.1 Million CNY | 10.07% |
| 2011 Q2 | 50.01 Million CNY | 58.25% |
| 2011 Q4 | 41.65 Million CNY | 19.56% |
| 2011 Q3 | 34.83 Million CNY | -30.35% |
| 2010 Q3 | 35.3 Million CNY | 0.0% |
| 2010 Q4 | 44.89 Million CNY | 27.17% |
| 2010 FY | 143.63 Million CNY | 38.85% |
| 2009 FY | 103.44 Million CNY | 19.85% |
| 2008 FY | 86.31 Million CNY | 0.0% |